Search News Releases
You can use the filters to refine your search.
Displaying 1 - 20 of 3847
HIV has an “early and substantial” impact on aging in infected people, accelerating biological changes in the body associated with normal aging within just two to three years of infection.
UCLA has received a $59 million Clinical and Translational Science Award from the National Center for Advancing Translational Sciences (NCATS). The five-year award supports the UCLA Clinical and Translational Science Institute (CTSI), a research partnership among UCLA, Charles Drew University of Medicine and Science, the Lundquist Institute at Harbor-UCLA Medical Center, and Cedars-Sinai Medical Center.
UCLA Health’s Ahmanson Translational Theranostics Division, part of the Department of Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA, has been designated a Comprehensive Radiopharmaceutical Therapy Center of Excellence by the Society of Nuclear Medicine & Molecular Imaging (SNMMI).
Medicare could waste up to $605 million per year on the controversial Alzheimer’s drug aducanumab if it is eventually approved for widespread use because it is supplied in vials containing fixed doses that may not be appropriate for all patients–resulting in the trashing of large volumes of unused drug.
UCLA Health is one of only ten clinical centers nationwide to receive designation as a Clinical Center by the Alliance to Cure Cavernous Malformation for the treatment of cerebral cavernous malformations (CCM).
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received more than $6.8 million in grants from the California Institute for Regenerative Medicine, the state’s stem cell agency, to help develop new stem cell-based technologies to improve patient care.
A new study from UCLA researchers indicates adult flu vaccination rates have declined in states with low rates of COVID-19 vaccination, which the authors say may be a harbinger of declining trust in public health and could make some populations more vulnerable to preventable disease.
UCLA Mattel Children’s Hospital ranked in California’s top 5 and once again was recognized for broad excellence in a widely watched assessment of pediatric care.
Preclinical studies using laboratory mice that model human infection with the virus that causes COVID-19 indicate an inexpensive, readily available amino acid might limit the effects of the disease.
UCLA Health has received the Mitral Valve Repair Reference Center Award from the American Heart Association and the Mitral Foundation for a demonstrated record of superior clinical outcomes resulting from evidence-based, guideline-directed care and high volume in mitral valve repair for degenerative mitral valve regurgitation.
A new study in mice finds that a gene therapy developed by a UCLA researcher appears to correct a rare creatine deficiency disorder that commonly results in intellectual disabilities, problems with speech, involuntary movements and recurrent seizures.
Dr. Cristina Puig Saus and Dr. Gatien Moriceau, UCLA Jonsson Comprehensive Cancer Center researchers, have received the Young Investigator Award from the Melanoma Research Alliance, the largest nonprofit funder of melanoma research.
Dr. Zhentao Yang and Dr. Yujue Wang, UCLA Jonsson Comprehensive Cancer Center researchers, have been chosen as dermatology fellows by the Melanoma Research Alliance, the largest nonprofit funder of melanoma research. The year-long fellowship provides funding to promising clinicians and researchers-in-training to help advance research in melanoma prevention and early detection.
New UCLA research points to a novel treatment for respiratory depression associated with opioid use by administering electrical pulses to the back of the neck, helping patients regain respiratory control following high dosage opioids.